loading
Schlusskurs vom Vortag:
$38.18
Offen:
$38.35
24-Stunden-Volumen:
471.01K
Relative Volume:
0.64
Marktkapitalisierung:
$2.19B
Einnahmen:
$32.87M
Nettoeinkommen (Verlust:
$674.31M
KGV:
3.3195
EPS:
11.36
Netto-Cashflow:
$-330.11M
1W Leistung:
-2.81%
1M Leistung:
-0.05%
6M Leistung:
+9.81%
1J Leistung:
-17.77%
1-Tages-Spanne:
Value
$37.38
$38.78
1-Wochen-Bereich:
Value
$36.99
$40.10
52-Wochen-Spanne:
Value
$23.41
$62.58

Agios Pharmaceuticals Inc Stock (AGIO) Company Profile

Name
Firmenname
Agios Pharmaceuticals Inc
Name
Telefon
617-649-8600
Name
Adresse
88 SIDNEY STREET, CAMBRIDGE, MA
Name
Mitarbeiter
488
Name
Twitter
@AgiosPharma
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
AGIO's Discussions on Twitter

Vergleichen Sie AGIO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
AGIO
Agios Pharmaceuticals Inc
37.71 2.22B 32.87M 674.31M -330.11M 11.36
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
391.02 100.52B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
580.70 61.43B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
446.51 59.29B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
712.20 43.09B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
306.05 35.42B 3.81B -644.79M -669.77M -6.24

Agios Pharmaceuticals Inc Stock (AGIO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-02-24 Eingeleitet H.C. Wainwright Buy
2024-10-16 Eingeleitet Scotiabank Sector Outperform
2024-10-10 Fortgesetzt Raymond James Outperform
2024-09-27 Herabstufung Leerink Partners Outperform → Market Perform
2024-02-08 Eingeleitet Cantor Fitzgerald Overweight
2023-02-03 Eingeleitet Piper Sandler Overweight
2022-11-17 Hochstufung Goldman Sell → Neutral
2022-07-27 Hochstufung SVB Leerink Mkt Perform → Outperform
2021-12-03 Eingeleitet BofA Securities Buy
2021-07-30 Herabstufung Goldman Neutral → Sell
2021-07-01 Eingeleitet Raymond James Mkt Perform
2021-06-10 Eingeleitet H.C. Wainwright Buy
2021-03-01 Herabstufung JP Morgan Overweight → Neutral
2021-03-01 Hochstufung SVB Leerink Mkt Perform → Outperform
2021-02-26 Herabstufung SVB Leerink Outperform → Mkt Perform
2020-10-22 Hochstufung Barclays Equal Weight → Overweight
2020-03-04 Eingeleitet Barclays Equal Weight
2019-11-26 Eingeleitet Cantor Fitzgerald Overweight
2019-09-23 Hochstufung Guggenheim Neutral → Buy
2019-05-23 Fortgesetzt Goldman Neutral
2019-02-15 Hochstufung SVB Leerink Mkt Perform → Outperform
2018-09-25 Eingeleitet Leerink Partners Mkt Perform
2018-05-23 Eingeleitet Citigroup Buy
2018-04-11 Bestätigt Credit Suisse Outperform
2018-02-15 Bestätigt Needham Buy
2018-02-15 Bestätigt SunTrust Buy
2017-09-15 Eingeleitet RBC Capital Mkts Outperform
2017-08-10 Bestätigt Needham Buy
2017-08-08 Bestätigt SunTrust Buy
2017-08-02 Hochstufung Leerink Partners Mkt Perform → Outperform
2017-06-26 Herabstufung Janney Buy → Neutral
2017-01-17 Hochstufung Oppenheimer Perform → Outperform
2016-10-24 Eingeleitet Needham Buy
2016-06-13 Hochstufung JP Morgan Neutral → Overweight
2016-05-18 Bestätigt SunTrust Buy
Alle ansehen

Agios Pharmaceuticals Inc Aktie (AGIO) Neueste Nachrichten

pulisher
06:17 AM

What moving averages say about Agios Pharmaceuticals Inc.July 2025 Market Mood & Weekly Momentum Picks - Newser

06:17 AM
pulisher
01:22 AM

What technical models suggest about Agios Pharmaceuticals Inc.’s comeback2025 Top Decliners & Community Verified Trade Alerts - Newser

01:22 AM
pulisher
12:57 PM

Full technical analysis of Agios Pharmaceuticals Inc. stock2025 Technical Overview & Risk Controlled Swing Trade Alerts - Newser

12:57 PM
pulisher
12:36 PM

Should you wait for a breakout in Agios Pharmaceuticals Inc.Short Setup & Fast Gain Stock Trading Tips - Newser

12:36 PM
pulisher
12:17 PM

Has Agios Pharmaceuticals Inc. found a price floorJuly 2025 Setups & Detailed Earnings Play Strategies - Newser

12:17 PM
pulisher
Aug 30, 2025

Can trapped investors hope for a rebound in Agios Pharmaceuticals IncWeekly Stock Summary & Technical Buy Zone Confirmations - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Is Agios Pharmaceuticals Inc. stock poised for growth2025 Earnings Impact & Technical Analysis for Trade Confirmation - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Price momentum metrics for Agios Pharmaceuticals Inc. explainedWeekly Investment Summary & Technical Pattern Based Signals - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Exit strategy if you’re trapped in Agios Pharmaceuticals Inc.July 2025 EndofMonth & Fast Entry High Yield Stock Tips - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Agios Pharmaceuticals Inc.’s volatility index tracking explainedCPI Data & Weekly Breakout Stock Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Chart based exit strategy for Agios Pharmaceuticals Inc.Profit Target & Consistent Profit Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Price action breakdown for Agios Pharmaceuticals Inc.July 2025 Macro Moves & Weekly High Return Stock Forecasts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Published on: 2025-08-30 16:42:25 - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Historical volatility pattern of Agios Pharmaceuticals Inc. visualized2025 Year in Review & High Accuracy Trade Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Heatmap analysis for Agios Pharmaceuticals Inc. and competitorsJuly 2025 Catalysts & Risk Controlled Stock Pick Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Should you hold or exit Agios Pharmaceuticals Inc. nowMarket Activity Report & Low Risk Entry Point Guides - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Does Agios Pharmaceuticals Inc. show high probability of rebound2025 Momentum Check & Smart Money Movement Tracker - Newser

Aug 30, 2025
pulisher
Aug 29, 2025

How sentiment analysis helps forecast Agios Pharmaceuticals Inc.Quarterly Market Summary & Free Risk Controlled Daily Trade Plans - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Will Agios Pharmaceuticals Inc. stock recover after recent dropJuly 2025 Trends & AI Powered Buy and Sell Recommendations - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Agios Pharmaceuticals Inc. stock trendline breakdownWeekly Trading Summary & Advanced Swing Trade Entry Alerts - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Can trapped investors hope for a rebound in Agios Pharmaceuticals Inc.July 2025 Review & Consistent Income Trade Ideas - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Automated trading signals detected on Agios Pharmaceuticals Inc.Portfolio Risk Summary & Low Drawdown Trading Techniques - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Long term hold vs stop loss in Agios Pharmaceuticals Inc.Market Performance Summary & Weekly Setup with High ROI Potential - Newser

Aug 29, 2025
pulisher
Aug 29, 2025

Agios Pharmaceuticals, Inc. (AGIO) Advances Pipeline With Tebapivat, AG-236 in Rare Blood Disorders - Yahoo Finance

Aug 29, 2025
pulisher
Aug 29, 2025

Combining machine learning predictions for Agios Pharmaceuticals Inc.Gold Moves & Smart Swing Trading Techniques - Newser

Aug 29, 2025
pulisher
Aug 28, 2025

Can a trend reversal in Agios Pharmaceuticals Inc. lead to recovery2025 Year in Review & Stepwise Trade Signal Guides - Newser

Aug 28, 2025
pulisher
Aug 28, 2025

How to track smart money flows in Agios Pharmaceuticals Inc.2025 Retail Activity & Real-Time Volume Triggers - Newser

Aug 28, 2025

Finanzdaten der Agios Pharmaceuticals Inc-Aktie (AGIO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Agios Pharmaceuticals Inc-Aktie (AGIO) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Scadden David
Director
Aug 27 '25
Sale
40.00
200
8,000
17,603
$24.87
price down icon 0.96%
$84.61
price up icon 1.09%
$23.70
price down icon 2.95%
$100.00
price down icon 1.89%
$136.10
price up icon 0.84%
biotechnology ONC
$306.05
price up icon 2.72%
Kapitalisierung:     |  Volumen (24h):